Page last updated: 2024-10-24

carprofen and Malignant Melanoma

carprofen has been researched along with Malignant Melanoma in 1 studies

carprofen: RN given refers to cpd without isomeric designation
carprofen : Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs.

Research Excerpts

ExcerptRelevanceReference
"Indomethacin significantly enhances the depressed levels of lymphocyte proliferation to the mitogens phytohemagglutinin and concanavalin A in melanoma patients."7.66Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression. ( Balch, CM; Tilden, AB, 1982)
"Indomethacin significantly enhances the depressed levels of lymphocyte proliferation to the mitogens phytohemagglutinin and concanavalin A in melanoma patients."3.66Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression. ( Balch, CM; Tilden, AB, 1982)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tilden, AB1
Balch, CM1

Other Studies

1 other study available for carprofen and Malignant Melanoma

ArticleYear
Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression.
    Surgery, 1982, Volume: 92, Issue:3

    Topics: Adult; Aged; Carbazoles; Concanavalin A; Cyclic AMP; Humans; Immunity; Immunosuppression Therapy; In

1982